Artificial Implantable Kidney Work Imperiled by Funding Worries

July 22, 2019, 9:41 AM

An implantable artificial kidney is less than five years from clinical trials in humans, but it’s $11 million short of completing the work to get there and funding options are drying up.

“We can get to the first patient [in a clinical trial] within five years or less with the right amount of focused engineering effort…because it’s not so much a technology limitation as it is a resource limitation,” said Shuvo Roy, a professor of bioengineering at the University of California, San Francisco and technical director of The Kidney Project, which is developing the device.

Despite President Donald Trump’s ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.